GlassScriptPhysician profile
James Kenneth Ford
NPI 1285665182
$67,490.32
in general payments reported to CMS, 2019-2025
28 companies · $16.73 in 2025
The $16.73 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $16K · 2021: $8,291 · 2022: $18K · 2023: $7,962 · 2024: $244 · 2025: $16.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Food and Beverage: $1,898 · Travel and Lodging: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Food and Beverage | $1,897.73 |
| Travel and Lodging | $324.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $56,255.02 | 2019-2023 | Definity |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4,754.80 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $1,736.08 | 2019-2022 | |
| Abiomed | $825.72 | 2019-2023 | Impella |
| Novartis Pharmaceuticals Corporation | $654.07 | 2019-2023 | |
| Amgen INC. | $490.72 | 2019-2023 | Repatha |
| Abbott Laboratories | $474.92 | 2019-2024 | Mitraclip, Cardiomems |
| Medtronic, INC. | $425.40 | 2021-2023 | Azure Xt Dr Mri Surescan |
| Inari Medical, INC. | $354.95 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $268.13 | 2019-2024 | Watchman Access System, Watchman Flx |
| Janssen Pharmaceuticals, INC | $203.87 | 2019-2023 | Xarelto |
| Shockwave Medical, INC | $178.62 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Medical L6 Intravascular Lithotripsy (Ivl) Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Pfizer INC. | $160.73 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.43 | 2022-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $96.46 | 2023 | Eliquis, Camzyos |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $92.07 | 2021 | |
| Cvrx, INC. | $87.50 | 2022 | |
| Sanofi-Aventis U.S. LLC | $81.71 | 2019-2023 | |
| Elutia, INC. | $59.82 | 2019 | |
| Astellas Pharma US INC | $36.74 | 2019 | |
| Irhythm Technologies, INC. | $32.95 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $25.74 | 2019 | |
| Philips North America LLC | $16.31 | 2023 | |
| Penumbra, INC. | $14.74 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $13.74 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.23 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.85 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.